"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...

Google's Wear OS will see health tracking upgrades courtesy of Masimo, the patent-holder responsible for blocking Apple Watch ...

Global medical innovator Masimo has announced a partnership with Google to develop a new reference platform for original ...

The devices became standard issue in hospitals, making Masimo the gold standard in noninvasive monitoring of blood oxygen levels, as well as the pulse signal and fluid responsiveness in patients ...

The latest partnership is expected to significantly strengthen Masimo’s patient monitoring business. Per Masimo, by incorporating its biosensing technologies and standardizing smartwatch devices ...

The devices, primarily sold to hospitals, leapt in popularity during the COVID-19 pandemic because of their ability to remotely monitor patients. Masimo, which went public in 2007, is expected to ...

By incorporating Masimo’s breakthrough biosensing technologies – based on its decades of expertise developing industry-leading hospital monitoring solutions – and standardizing smartwatch ...

on the Updated GOLD Proxy Card MasimoCorporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today mailed a ...

which includes the Masimo W1 and the upcoming Masimo Freedom wearables, known for their precision in health monitoring. Qualcomm’s Snapdragon W5+ Gen 1 will power these next-gen devices ...

The powerhouse combination of Masimo’s clinically proven, breakthrough biosensing technologies – based on its decades of expertise designing industry-leading hospital monitoring solutions – and ...